go-v.orgdoi

Fifty Years of Minocycline and Its Evolution: A Dermatological Perspective.

Hilary E Baldwin, Daniel B Ward · PubMed · 2021

  • DOI 10.36849/jdd..6370
  • Publisher National Institutes of Health
  • Type article
  • Issued 2021

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

PubMed · National Institutes of Health · article · 2021

Abstract

2021 is the 50th anniversary of the FDA approval of minocycline (MCN). While many other antibiotics have become obsolete during this time, MCN continues to be quite useful. In dermatology, MCN is used prominently in acne vulgaris, and is also employed in many other dermatological conditions because of its molecular and pharmacological properties. In this article, we review the history of minocycline, and outline the evolution of the drug since its inception. Based on its existing longstanding utility and continued innovations in formulation and delivery systems, we postulate that it will continue to have a prominent position in the dermatologist’s armamentarium. J Drugs Dermatol.

2021;20(10):1031-1036. doi:10.36849/JDD.6370.

Open the resolved locator · 10.36849/jdd..6370

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 04:01 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://pubmed.ncbi.nlm.nih.gov/34636517
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.